273 related articles for article (PubMed ID: 21281255)
1. Increase of regulatory T cells in ileal mucosa of untreated pediatric Crohn's disease patients.
Reikvam DH; Perminow G; Lyckander LG; Gran JM; Brandtzaeg P; Vatn M; Carlsen HS
Scand J Gastroenterol; 2011 May; 46(5):550-60. PubMed ID: 21281255
[TBL] [Abstract][Full Text] [Related]
2. Increased FOXP3 expression in small-bowel mucosa of children with coeliac disease and type I diabetes mellitus.
Vorobjova T; Uibo O; Heilman K; Rägo T; Honkanen J; Vaarala O; Tillmann V; Ojakivi I; Uibo R
Scand J Gastroenterol; 2009; 44(4):422-30. PubMed ID: 19096978
[TBL] [Abstract][Full Text] [Related]
3. IL-15 interferes with suppressive activity of intestinal regulatory T cells expanded in Celiac disease.
Zanzi D; Stefanile R; Santagata S; Iaffaldano L; Iaquinto G; Giardullo N; Lania G; Vigliano I; Vera AR; Ferrara K; Auricchio S; Troncone R; Mazzarella G
Am J Gastroenterol; 2011 Jul; 106(7):1308-17. PubMed ID: 21468011
[TBL] [Abstract][Full Text] [Related]
4. Immunoregulatory pathways are active in the small intestinal mucosa of patients with potential celiac disease.
Borrelli M; Salvati VM; Maglio M; Zanzi D; Ferrara K; Santagata S; Ponticelli D; Aitoro R; Mazzarella G; Lania G; Gianfrani C; Auricchio R; Troncone R
Am J Gastroenterol; 2013 Nov; 108(11):1775-84. PubMed ID: 24060758
[TBL] [Abstract][Full Text] [Related]
5. FoxP3(+)CD4(+)CD25(+) T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease.
Kelsen J; Agnholt J; Hoffmann HJ; Rømer JL; Hvas CL; Dahlerup JF
Clin Exp Immunol; 2005 Sep; 141(3):549-57. PubMed ID: 16045746
[TBL] [Abstract][Full Text] [Related]
6. Increased number and activation of colonic macrophages in pediatric patients with untreated Crohn's disease.
Perminow G; Reikvam DH; Lyckander LG; Brandtzaeg P; Vatn MH; Carlsen HS
Inflamm Bowel Dis; 2009 Sep; 15(9):1368-78. PubMed ID: 19322902
[TBL] [Abstract][Full Text] [Related]
7. Expression of CD4+ forkhead box P3 (FOXP3)+ regulatory T cells in inflammatory bowel disease.
Wang Y; Liu XP; Zhao ZB; Chen JH; Yu CG
J Dig Dis; 2011 Aug; 12(4):286-94. PubMed ID: 21791023
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-17 immunity in pediatric Crohn disease and ulcerative colitis.
Hölttä V; Klemetti P; Salo HM; Koivusalo A; Pakarinen M; Westerholm-Ormio M; Kolho KL; Vaarala O
J Pediatr Gastroenterol Nutr; 2013 Sep; 57(3):287-92. PubMed ID: 23974060
[TBL] [Abstract][Full Text] [Related]
9. Infiltration of Foxp3- and Toll-like receptor-4-positive cells in the intestines of children with food allergy.
Westerholm-Ormio M; Vaarala O; Tiittanen M; Savilahti E
J Pediatr Gastroenterol Nutr; 2010 Apr; 50(4):367-76. PubMed ID: 20216098
[TBL] [Abstract][Full Text] [Related]
10. Impaired control of effector T cells by regulatory T cells: a clue to loss of oral tolerance and autoimmunity in celiac disease?
Hmida NB; Ben Ahmed M; Moussa A; Rejeb MB; Said Y; Kourda N; Meresse B; Abdeladhim M; Louzir H; Cerf-Bensussan N
Am J Gastroenterol; 2012 Apr; 107(4):604-11. PubMed ID: 22108452
[TBL] [Abstract][Full Text] [Related]
11. CD4+ CD25+ FOXP3+ T cell frequency in the peripheral blood is a biomarker that distinguishes intestinal tuberculosis from Crohn's disease.
Tiwari V; Kedia S; Garg SK; Rampal R; Mouli VP; Purwar A; Mitra DK; Das P; Dattagupta S; Makharia G; Acharya SK; Ahuja V
PLoS One; 2018; 13(2):e0193433. PubMed ID: 29489879
[TBL] [Abstract][Full Text] [Related]
12. Frequency of Foxp3+CD4CD25+ T cells is associated with the phenotypes of allergic asthma.
Matsumoto K; Inoue H; Fukuyama S; Kan-O K; Eguchi-Tsuda M; Matsumoto T; Moriwaki A; Nakano T; Nakanishi Y
Respirology; 2009 Mar; 14(2):187-94. PubMed ID: 19192224
[TBL] [Abstract][Full Text] [Related]
13. T2 enhances in situ level of Foxp3+ regulatory cells and modulates inflammatory cytokines in Crohn's disease.
Li G; Ren J; Wang G; Gu G; Hu D; Ren H; Hong Z; Wu X; Liu S; Li J
Int Immunopharmacol; 2014 Feb; 18(2):244-8. PubMed ID: 24369313
[TBL] [Abstract][Full Text] [Related]
14. Increased number of FoxP3+CD4+ regulatory T cells in inflammatory bowel disease.
Ban H; Andoh A; Shioya M; Nishida A; Tsujikawa T; Fujiyama Y
Mol Med Rep; 2008; 1(5):647-50. PubMed ID: 21479463
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
[TBL] [Abstract][Full Text] [Related]
16. No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes.
Brusko T; Wasserfall C; McGrail K; Schatz R; Viener HL; Schatz D; Haller M; Rockell J; Gottlieb P; Clare-Salzler M; Atkinson M
Diabetes; 2007 Mar; 56(3):604-12. PubMed ID: 17327427
[TBL] [Abstract][Full Text] [Related]
17. CD4+CD25+ regulatory T cells in irritable bowel syndrome patients.
Holmén N; Isaksson S; Simrén M; Sjövall H; Ohman L
Neurogastroenterol Motil; 2007 Feb; 19(2):119-25. PubMed ID: 17244166
[TBL] [Abstract][Full Text] [Related]
18. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.
Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S
Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820
[TBL] [Abstract][Full Text] [Related]
19. The role of FoxP3+CD4+CD25hi Tregs in the pathogenesis of myasthenia gravis.
Zhang Y; Wang HB; Chi LJ; Wang WZ
Immunol Lett; 2009 Jan; 122(1):52-7. PubMed ID: 19111574
[TBL] [Abstract][Full Text] [Related]
20. Changes of regulatory T cells and FoxP3 gene expression in the aging process and its relationship with lung tumors in humans and mice.
Pan XD; Mao YQ; Zhu LJ; Li J; Xie Y; Wang L; Zhang GB
Chin Med J (Engl); 2012 Jun; 125(11):2004-11. PubMed ID: 22884069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]